11-57543072-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001105565.3(SMTNL1):āc.430G>Cā(p.Ala144Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000211 in 1,609,612 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001105565.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMTNL1 | NM_001105565.3 | c.430G>C | p.Ala144Pro | missense_variant | 2/8 | ENST00000527972.6 | NP_001099035.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMTNL1 | ENST00000527972.6 | c.430G>C | p.Ala144Pro | missense_variant | 2/8 | 5 | NM_001105565.3 | ENSP00000432651.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000104 AC: 25AN: 240174Hom.: 1 AF XY: 0.0000920 AC XY: 12AN XY: 130396
GnomAD4 exome AF: 0.0000220 AC: 32AN: 1457406Hom.: 1 Cov.: 33 AF XY: 0.0000207 AC XY: 15AN XY: 724628
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 25, 2024 | The c.430G>C (p.A144P) alteration is located in exon 1 (coding exon 1) of the SMTNL1 gene. This alteration results from a G to C substitution at nucleotide position 430, causing the alanine (A) at amino acid position 144 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at